Physician profile
Stuart Bussell
NPI 1881636447
$688.97
in general payments reported to CMS, 2019-2025
10 companies · $38.72 in 2025
The $38.72 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $35.32 · 2021: $180 · 2023: $72.73 · 2024: $257 · 2025: $38.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $365.93 | 2021-2024 | Interstim |
| Kci USA, INC. | $72.73 | 2023 | Abthera Advance |
| W. L. Gore & Associates, INC. | $71.90 | 2024 | Gore Tag Conformable Thoracic Endoprosthesis |
| Kerecis Limited | $38.72 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| E.R. Squibb & Sons, L.L.C. | $35.32 | 2020 | |
| Amag Pharmaceuticals, INC. | $34.57 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $18.90 | 2019 | |
| Exelixis INC. | $18.00 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $16.68 | 2019 | |
| Sirtex Medical INC | $16.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Bussell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.